Expression of DNA‑dependent protein kinase catalytic subunit in laryngeal squamous cell carcinoma and its importance

Sun,Jian‑Song; Yang,Xiu‑Hai

doi:10.3892/etm.2018.5826

Expression of DNA‑dependent protein kinase catalytic subunit in laryngeal squamous cell carcinoma and its importance

Authors:
- Jian‑Song Sun
- Xiu‑Hai Yang
View Affiliations

Affiliations: Department of Otolaryngology‑Head and Neck Surgery, The People's Hospital of Guizhou Province, Guiyang, Guizhou 550002, P.R. China
Published online on: February 1, 2018 https://doi.org/10.3892/etm.2018.5826
Pages: 3295-3301
Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to explore the expression and distribution of DNA‑dependent protein kinase catalytic subunit (DNA‑PKcs) in tumor tissues and adjacent normal mucosa tissues of patients with laryngeal squamous cell carcinoma (LSCC), and further analyze the association between the expression and the clinicopathological parameters of patients with LSCC. Clinical data of tumor tissues and corresponding adjacent normal mucosa tissues of pathologically diagnosed LSCC in 96 cases were collected in the present study. Of these specimens, the mRNA and protein expression levels of DNA‑PKcs in LSCC tissues and the adjacent normal mucosa tissues were analyzed via reverse transcription‑quantitative polymerase chain reaction and western blot analysis. Immunohistochemistry was used to detect expression and distribution of DNA‑PKcs protein in LSCC tissues and corresponding adjacent normal mucosa tissues. The association between DNA‑PKcs expression and the specific clinicopathologic features was evaluated by the χ2 test. Kaplan‑Meier and Cox proportional hazards regression models were used to analyze the data. It was revealed that the expression of DNA‑PKcs mRNA and protein was significantly higher in LSCC tissues than the adjacent normal mucosa tissues (P<0.05). DNA‑PKcs was expressed predominantly in the nucleus. DNA‑PKcs expression showed significant correlation with the differentiation degree of LSCC (P<0.05), and changes of DNA‑PKcs expression gradually increased with the decrease of the differentiation degree. However, DNA‑PKcs expression was not significantly associated with sex, age, lymph node metastasis or TMN stage (P>0.05). Patients with LSCC exhibited higher DNA‑PKcs expression had markedly shorter survival than those with lower DNA‑PKcs expression. In conclusion, the present results suggested that the expression levels of DNA‑PKcs were significantly increased in LSCC tumor tissues than in adjacent normal mucosa. DNA‑PKcs expression was correlated with differentiation of LSCC, and may become a novel prognostic marker for patients with LSCC.

View Figures

View References

1	Mojica-Manosa P, Reidy J, Wilson K and Douglas W: Larynx squamous cell carcinoma: Concepts and future directions. Surg Oncol Clin N Am. 13:99–112. 2004. View Article : Google Scholar : PubMed/NCBI
2	Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar : PubMed/NCBI
3	Almadori G, Bussu F, Cadoni G, Galli J, Paludetti G and Maurizi M: Molecular markers in laryngeal squamous cell carcinoma: Towards an integrated clinicobiological approach. Eur J Cancer. 41:683–693. 2005. View Article : Google Scholar : PubMed/NCBI
4	Ou G, Itasaka S, Zeng L, Shibuya K, Yi J, Harada H and Hiraoka M: Usefulness of HIF-1 imaging for determining optimal timing of combining bevacizumab and radiotherapy. Int J Radiat Oncol Biol Phys. 75:463–467. 2009. View Article : Google Scholar : PubMed/NCBI
5	García-Fernández E, De Diego JI, Collantes-Bellido E, Mendiola M, Prim MP, Pérez-Fernández E, Miguel-Martín M, Nistal M and Hardisson D: Aurora B kinase expression in laryngeal squamous cell carcinoma and its prognostic implications. Histopathology. 58:368–376. 2011. View Article : Google Scholar : PubMed/NCBI
6	Shi Y, Gong HL, Zhou L, Tian J and Wang Y: CD24: A novel cancer biomarker in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 74:78–85. 2012. View Article : Google Scholar : PubMed/NCBI
7	Kong X, Shen Y, Jiang N, Fei X and Mi J: Emerging roles of DNA-PK besides DNA repair. Cell Signal. 23:1273–1280. 2011. View Article : Google Scholar : PubMed/NCBI
8	Neal JA and Meek K: Choosing the right path: Does DNA-PK help make the decision. Mutat Res. 711:73–86. 2011. View Article : Google Scholar : PubMed/NCBI
9	Hill R and Lee PW: The DNA-dependent protein kinase (DNA-PK): More than just a case of making ends meet. Cell Cycle. 9:3460–3469. 2010. View Article : Google Scholar : PubMed/NCBI
10	Meek K, Dang V and Lees-Miller SP: DNA-PK: The means to justify the ends. Adv Immunol. 99:33–58. 2008. View Article : Google Scholar : PubMed/NCBI
11	Salles B, Calsou P, Frit P and Muller C: The DNA repair complex DNA-PK, a pharmacological target in cancer chemotherapy and radiotherapy. Pathol Biol (Paris). 54:185–193. 2006. View Article : Google Scholar : PubMed/NCBI
12	Yang J, Xu X, Hao Y, Chen J, Lu H, Qin J, Peng L and Chen B: Expression of DNA-PKcs and BRCA1 as prognostic indicators in nasopharyngeal carcinoma following intensity-modulated radiation therapy. Oncol Lett. 5:1199–1204. 2013. View Article : Google Scholar : PubMed/NCBI
13	Gottlieb TM and Jackson SP: The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen. Cell. 72:131–142. 1993. View Article : Google Scholar : PubMed/NCBI
14	Ren JH, Dai XF, Yan GL, Jin M, Liu CW, Yang KY, Wu G and Ma CM: Acute oral mucositis in nasopharyngeal carcinoma patients treated with radiotherapy: Association with genetic polymorphism in DNA DSB repair genes. Int J Radiat Biol. 90:256–261. 2014. View Article : Google Scholar : PubMed/NCBI
15	Jackson SP: Sensing and repairing DNA double-strand breaks. Carcinogenesis. 23:687–696. 2002. View Article : Google Scholar : PubMed/NCBI
16	Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, Morita A, Nagawa H and Suzuki N: Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol. 25:461–468. 2004.PubMed/NCBI
17	Shintani S, Mihara M, Li C, Nakahara Y, Hino S, Nakashiro K and Hamakawa H: Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma. Cancer Sci. 94:894–900. 2003. View Article : Google Scholar : PubMed/NCBI
18	Um JH, Kwon JK, Kang CD, Kim MJ, Ju DS, Bae JH, Kim DW, Chung BS and Kim SH: Relationship between antiapoptotic molecules and metastatic potency and the involvement of DNA-dependent protein kinase in the chemosensitization of metastatic human cancer cells by epidermal growth factor receptor blockade. J Pharmacol Exp Ther. 311:1062–1070. 2004. View Article : Google Scholar : PubMed/NCBI
19	Tonotsuka N, Hosoi Y, Miyazaki S, Miyata G, Sugawara K, Mori T, Ouchi N, Satomi S, Matsumoto Y, Nakagawa K, et al: Heterogeneous expression of DNA-dependent protein kinase in esophageal cancer and normal epithelium. Int J Mol Med. 18:441–447. 2006.PubMed/NCBI
20	Moll U, Lau R, Sypes MA, Gupta MM and Anderson CW: DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues. Oncogene. 18:3114–3126. 1999. View Article : Google Scholar : PubMed/NCBI
21	Sallmyr A, Miller A, Gabdoulkhakova A, Safronova V, Henriksson G and Bredberg A: Expression of DNA-dependent protein kinase in human granulocytes. Cell Res. 14:331–340. 2004. View Article : Google Scholar : PubMed/NCBI
22	Holgersson A, Erdal H, Nilsson A, Lewensohn R and Kanter L: Expression of DNA-PKcs and Ku86, but not Ku70, differs between lymphoid malignancies. Exp Mol Pathol. 77:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
23	van der Burg M, van Dongen JJ and van Gent DC: DNA-PKcs deficiency in human: Long predicted, finally found. Curr Opin Allergy Clin Immunol. 9:503–509. 2009. View Article : Google Scholar : PubMed/NCBI
24	Hsu FM, Zhang S and Chen BP: Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment. Transl Cancer Res. 1:22–34. 2012.PubMed/NCBI
25	Razek AA and Huang BY: Soft tissue tumors of the head and neck: Imaging-based review of the WHO classification. Radiographics. 31:1923–1954. 2011. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Method. 25:402–408. 2001. View Article : Google Scholar
27	Xu LZ and Yang WT: The criteria for judging the results of immunohistochemical reaction. Zhong Guo Ai Zheng Za Zhi. 6:229–231. 1996.(In Chinese).
28	Takata M, Sasaki MA, Sonoda E, Morrison C, Hashimoto M, Utsumi H, Yamaguchi-Iwai Y, Shinohara A and Takeda S: Homologous recombination and non-homologous end-joining pathways of DNA double-strand bread repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 17:5497–5508. 1998. View Article : Google Scholar : PubMed/NCBI
29	Rothkamm K, Kühne M, Jeggo PA and Löbrich M: Radiation-induced genomic rearrangement formed nonhomologous end -joining of DNA double-strand breaks. Cancer Res. 61:3886–2893. 2001.PubMed/NCBI
30	Bouchaert P, Guerif S, Debiais C, Irani J and Fromont G: DNA-PKcs expression predicts response to radiotherapy in prostate cancer. Int J Radiat Oncol Biol Phys. 84:1179–1185. 2012. View Article : Google Scholar : PubMed/NCBI
31	Lee HS, Choe G, Park KU, Park DJ, Yang HK, Lee BL and Kim WH: Altered expression of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) during gastric carcinogenesis and its clinical implications on gastric cancer. Int J Oncol. 31:859–866. 2007.PubMed/NCBI
32	Nacht M, Strasser A, Chan YR, Harris AW, Schlissel M, Bronson RT and Jacks T: Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 15:2055–2066. 1996. View Article : Google Scholar
33	Treilleux I, Chapot B, Goddard S, Pisani P, Angèle S and Hall J: The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase. Histopathology. 51:63–69. 2007. View Article : Google Scholar : PubMed/NCBI
34	Someya M, Sakata K, Matsumoto Y, Yamamoto H, Monobe M, Ikeda H, Ando K, Hosoi Y, Suzuki N and Hareyama M: The association of DNA-dependent protein kinase activity with chromosomal instability and risk cancer. Carcinohenesis. 27:117–122. 2006. View Article : Google Scholar
35	Carter T, Vancurová I, Sun I, Lou W and DeLeon S: A DNA-activated protein kinase from HeLa cell nuclei. Mol Cell Boil. 10:6460–6471. 1990. View Article : Google Scholar
36	Ren F, Yang ZL, Tan X, Liu D, Zou Q, Yuan Y, Li J, Liang L, Zeng G and Chen S: DNA-PKcs and Ku70 are predictive markers for poor prognosis of patients with gall bladder malignancies. Appl Immunohistochem Mol Morphol. 22:741–747. 2014. View Article : Google Scholar : PubMed/NCBI
37	Abdel-Fatah T, Arora A, Agarwal D, Moseley P, Perry C, Thompson N, Green AR, Rakha E, Chan S, Ball G, et al: Adverse prognostic and predictive significance of low DNA-PKcs expression in early-stage breast cancers. Breast Cancer Res Treat. 146:309–320. 2014. View Article : Google Scholar : PubMed/NCBI